BusinessTop Multinational BioTech Organization and Large Public Agency Select TransceptaBy Nasdaq OMXNov 30, 2017, 1:24 PM UTC
BusinessBiotricity Recognizes Remote Monitoring is Key to Chronic Care ManagementBy Nasdaq OMXNov 29, 2017, 1:02 PM UTC
BusinessEmerald Health Therapeutics, Inc. Acquires Shares of Vanc Pharmaceuticals Inc.By Nasdaq OMXNov 29, 2017, 12:00 PM UTC
BusinessCytovance Biologics, Inc. announces Bexion Pharmaceuticals Inc. has chosen Cytovance to manufacture the protein component and active ingredient of Bexion’s first clinical compound, BXQ-350By Nasdaq OMXNov 28, 2017, 10:00 AM UTC
BusinessExosome Diagnostics Announces National Medicare Reimbursement Rate Set at $760 for its Prostate Cancer IntelliScore TestBy Nasdaq OMXNov 27, 2017, 1:16 PM UTC
BusinessEmerald Health Therapeutics Completes Investment in Licensed Dealer Northern VineBy Nasdaq OMXNov 21, 2017, 12:00 PM UTC
BusinessEmerald Health Therapeutics Appoints Robert C. Hill, CPA, CA as Chief Financial Officer and Promotes Cheryl Evans, CPA, CA to Vice President FinanceBy Nasdaq OMXNov 20, 2017, 1:31 PM UTC
BusinessBeleave Announces $5 Million Non-Brokered Private Placement of UnitsBy Nasdaq OMXNov 20, 2017, 12:25 PM UTC
